Bargal R&D Investment

Bargal R&D Investment is an Israeli private investment firm specializing in the life sciences, biotechnology, and medical technology sectors. As the investment arm of the Bargal group—which includes the prominent laboratory equipment distributor Bargal Analytical Instruments—the firm provides venture capital and strategic support to innovative healthcare startups. Bargal R&D Investment leverages its deep technical expertise and extensive network within the Israeli scientific community to identify high-potential opportunities in diagnostics, molecular imaging, and therapeutics. Its portfolio has included notable companies such as Aposense, a developer of apoptosis-targeting imaging agents. The firm plays a vital role in the Israeli biotech ecosystem by bridging the gap between academic research and commercial medical innovation.